Prenetics Global (PRE)

• Market cap: $53.8M
• 1 day: -2.00%
• 5 days: -10.20%
• 1 month: -20.00%
• 3 months: -25.93%
• 6 months: -2.22%
• Year to date: -22.54%
• 1 year: -9.09%
• 5 years: -96.17%
• 10 years: -96.17%
• Sector: Industrials
• Industry: Laboratory Analytical Instruments

About: Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.

Employees: 320

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

48% more capital invested

Capital invested by funds: $4.47M [Q3] → $6.6M (+$2.13M) [Q4]

13% more funds holding

Funds holding: 8 [Q3] → 9 (+1) [Q4]

0.26% more ownership

Funds ownership: 10.45% [Q3] → 10.71% (+0.26%) [Q4]

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $9 105% upside
• Avg. target: $9 105% upside
• High target: $9 105% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Cantor Fitzgerald Ross Osborn 46% 1-year accuracy 21 / 46 met price target

105% upside $9

Overweight Reiterated

16 Jan 2025